Many drugs are known to form hydrates which affect their physical and thermodynamic properties, stability, dissolution rate and bioavailability.
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Therefore, it is important to characterize the water incorporated into the crystal lattice of a drug for development of a formulation with optimal pharmaceutical properties.
(
E3620, is a new benzamide gastroprokinetic agent. 1 In order to clarify the threedimensional molecular structure of the E3620 tetrahemihydrate (4.5-hydrate), an X-ray structure analysis was performed.
An E3620 4.5-hydrate was prepared by crystallization from a water solution to yield a white powder. A single crystal of the E3620 4.5-hydrate was obtained as a colorless prismatic crystal when crystallized by slow cooling. A single crystal has the approximate dimensions of 0.25 × 0.10 × 0.08 mm. The X-ray diffraction intensities were measured on a four-circle X-ray diffractometer (Rigaku RAXIS-IV) with graphite monochromated Mo Kα radiation, λ = 0.7107 Å, for a crystal sealed in a glass capillary. The intensities of 2089 independent reflections with a maximum 2θ value of 55.3˚ were measured. The crystal structure was solved by direct methods (SIR92) 2 and expanded using Fourier techniques (DIRDIF94). 3 Refinement of the crystal structure was carried out by full-matrix leastsquares calculations, including the anisotropic thermal parameters of the non-hydrogen atoms. All calculations were performed using teXsan. The crystal and experimental data are given in Table 1 . Figure 3 shows a projection of the crystal structure of the E3620 4.5-hydrate on the a -c plane. It appears that a water layer exists along the a axis. The final atomic coordinates and isotropic thermal parameters of the E3620 4.5-hydrate are listed in Table 2 . The bond distances and bond angles are shown in Table 4 Bond angles (˚) in E3620
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